Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study

Taro Kishi; Yasuhiro Iwama; Yuji Sasagawa; Shuichi Hiraoka; Aya Kamei; Nakao Iwata

doi:10.1111/pcn.13540

Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study

Taro Kishi
, Yasuhiro Iwama
, Yuji Sasagawa
, Shuichi Hiraoka
, Aya Kamei
, Nakao Iwata

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	365-366
Number of pages	2
Journal	Psychiatry and clinical neurosciences
Volume	77
Issue number	6
DOIs	https://doi.org/10.1111/pcn.13540
Publication status	Published - 06-2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

General Neuroscience
Neurology
Clinical Neurology
Psychiatry and Mental health

Access to Document

10.1111/pcn.13540

Cite this

@article{924138ae4f8f4381a6f6158ff248ea6c,

title = "Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study",

author = "Taro Kishi and Yasuhiro Iwama and Yuji Sasagawa and Shuichi Hiraoka and Aya Kamei and Nakao Iwata",

note = "Funding Information: The authors would like to thank MARUZEN-YUSHODO Co., Ltd. (https://kw.maruzen.co.jp/kousei-honyaku/) for the English language editing.",

year = "2023",

month = jun,

doi = "10.1111/pcn.13540",

language = "English",

volume = "77",

pages = "365--366",

journal = "Psychiatry and clinical neurosciences",

issn = "1323-1316",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "6",

}

TY - JOUR

T1 - Asenapine add-on treatment for schizophrenia adults who received antipsychotics

T2 - A 52-week, open-label study

AU - Kishi, Taro

AU - Iwama, Yasuhiro

AU - Sasagawa, Yuji

AU - Hiraoka, Shuichi

AU - Kamei, Aya

AU - Iwata, Nakao

N1 - Funding Information: The authors would like to thank MARUZEN-YUSHODO Co., Ltd. (https://kw.maruzen.co.jp/kousei-honyaku/) for the English language editing.

PY - 2023/6

Y1 - 2023/6

UR - https://www.scopus.com/pages/publications/85150031125

UR - https://www.scopus.com/pages/publications/85150031125#tab=citedBy

U2 - 10.1111/pcn.13540

DO - 10.1111/pcn.13540

M3 - Letter

C2 - 36856480

AN - SCOPUS:85150031125

SN - 1323-1316

VL - 77

SP - 365

EP - 366

JO - Psychiatry and clinical neurosciences

JF - Psychiatry and clinical neurosciences

IS - 6

ER -

Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this